CLL-584 Genomic Alterations and Outcomes With Fixed-Duration Ibrutinib + Venetoclax: Results From the Phase 3 GLOW Study in Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
CLL,genomic aberration,gene mutation,ibrutinib,chemoimmunotherapy,chronic lymphocytic leukemia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要